|
1
|
Cooper RA: Influence of increased membrane
cholesterol on membrane fluidity and cell function in human red
blood cells. J Supramol Struct. 8:413–430. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Needham D and Nunn RS: Elastic deformation
and failure of lipid bilayer membranes containing cholesterol.
Biophys J. 58:997–10094. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu J, Zhang Z, Shen WJ and Azhar S:
Cellular cholesterol delivery, intracellular processing and
utilization for biosynthesis of steroid hormones. Nutr Metab
(Lond). 7:472010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta A and Smith DA: The 2013 American
college of cardiology/American heart association guidelines on
treating blood cholesterol and assessing cardiovascular risk: A
busy practitioner's guide. Endocrinol Metab Clin North Am.
43:869–892. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seo HS and Choi MH: Cholesterol
homeostasis in cardiovascular disease and recent advances in
measuring cholesterol signatures. J Steroid Biochem Mol Biol.
153:72–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hovingh GK, Van Wijland MJ, Brownlie A,
Bisoendial RJ, Hayden MR, Kastelein JJ and Groen AK: The role of
the ABCA1 transporter and cholesterol efflux in familial
hypoalphalipoproteinemia. J Lipid Res. 44:1251–1255. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohashi R, Mu H, Wang X, Yao Q and Chen C:
Reverse cholesterol transport and cholesterol efflux in
atherosclerosis. QJM. 98:845–856. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thuahnai ST, Lund-Katz S, Dhanasekaran P,
de la Llera-Moya M, Connelly MA, Williams DL, Rothblat GH and
Phillips MC: Scavenger receptor class B type I-mediated cholesteryl
ester-selective uptake and efflux of unesterified cholesterol.
Influence of high density lipoprotein size and structure. J Biol
Chem. 279:12448–12455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chawla A, Boisvert WA, Lee CH, Laffitte
BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, et
al: A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in
cholesterol efflux and atherogenesis. Mol Cell. 7:161–171. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tontonoz P, Nagy L, Alvarez JG, Thomazy VA
and Evans RM: PPARgamma promotes monocyte/macrophage
differentiation and uptake of oxidized LDL. Cell. 93:241–252. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao R, Feng J and He G: miR-613 regulates
cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated
THP-1 macrophages. Biochem Biophys Res Commun. 448:329–334. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krakauer T, Li BQ and Young HA: The
flavonoid baicalin inhibits superantigen-induced inflammatory
cytokines and chemokines. FEBS Lett. 500:52–55. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Y, Li H, Gao Z and Xu H: Effects of
dietary baicalin supplementation on iron overload-induced mouse
liver oxidative injury. Eur J Pharmacol. 509:195–200. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li BQ, Fu T, Dongyan Y, Mikovits JA,
Ruscetti FW and Wang JM: Flavonoid baicalin inhibits HIV-1
infection at the level of viral entry. Biochem Biophys Res Commun.
276:534–538. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiu YW, Lin TH, Huang WS, Teng CY, Liou
YS, Kuo WH, Lin WL, Huang HI, Tung JN, Huang CY, et al: Baicalein
inhibits the migration and invasive properties of human hepatoma
cells. Toxicol Appl Pharmacol. 255:316–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abbasi P, Shamsasenjan K, Akbari AA
Movassaghpour, Akbarzadehlaleh P, Dehdilani N and Ejtehadifar M:
The effect of Baicalin as A PPAR activator on erythroid
differentiation of CD133 (+)hematopoietic stem cells in umbilical
cord blood. Cell J. 17:15–26. 2015.PubMed/NCBI
|
|
17
|
Yue J, Li B, Jing Q and Guan Q:
Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux
by targeting PPAR-γ and LXRα. Biochem Biophys Res Commun.
462:233–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng Y, Liu Y, Jin H, Pan S, Qian Y,
Huang C, Zeng Y, Luo Q, Zeng M and Zhang Z: Scavenger receptor B1
is a potential biomarker of human nasopharyngeal carcinoma and its
growth is inhibited by HDL-mimetic nanoparticles. Theranostics.
3:477–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yancey PG, Bortnick AE, Kellner-Weibel G,
de la Llera-Moya M, Phillips MC and Rothblat GH: Importance of
different pathways of cellular cholesterol efflux. Arterioscler
Thromb Vasc Biol. 23:712–719. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chinetti G, Gbaguidi FG, Griglio S, Mallat
Z, Antonucci M, Poulain P, Chapman J, Fruchart JC, Tedgui A,
Najib-Fruchart J, et al: CLA-1/SR-BI is expressed in
atherosclerotic lesion macrophages and regulated by activators of
peroxisome proliferator-activated receptors. Circulation.
101:2411–2417. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakaya K, Ayaori M, Hisada T, Sawada S,
Tanaka N, Iwamoto N, Ogura M, Yakushiji E, Kusuhara M, Nakamura H
and Ohsuzu F: Telmisartan enhances cholesterol efflux from THP-1
macrophages by activating PPARgamma. J Atheroscler Thromb.
14:133–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Voloshyna I, Hai O, Littlefield MJ,
Carsons S and Reiss AB: Resveratrol mediates anti-atherogenic
effects on cholesterol flux in human macrophages and endothelium
via PPARγ and adenosine. Eur J Pharmacol. 698:299–309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xi Y, Wu M, Li H, Dong S, Luo E, Gu M,
Shen X, Jiang Y, Liu Y and Liu H: Baicalin attenuates high fat
diet-induced obesity and liver dysfunction: Dose-response and
potential role of CaMKKβ/AMPK/ACC pathway. Cell Physiol Biochem.
35:2349–2359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao P, Liu L, Wang B, Li W, Fang X and
Guan S: Baicalin and geniposide attenuate atherosclerosis involving
lipids regulation and immunoregulation in ApoE−/- mice.
Eur J Pharmacol. 740:488–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rosenson RS, Brewer HB Jr, Davidson WS,
Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips
MC, Rader DJ, et al: Cholesterol efflux and atheroprotection:
Advancing the concept of reverse cholesterol transport.
Circulation. 125:1905–1919. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trigatti B, Covey S and Rizvi A: Scavenger
receptor class B type I in high-density lipoprotein metabolism,
atherosclerosis and heart disease: Lessons from gene-targeted mice.
Biochem Soc Trans. 32:116–120. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu X, Kozarsky K and Krieger M: Scavenger
receptor class B, type I-mediated [3H]cholesterol efflux to high
and low density lipoproteins is dependent on lipoprotein binding to
the receptor. J Biol Chem. 275:29993–30001. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jian B, de la Llera-Moya M, Ji Y, Wang N,
Phillips MC, Swaney JB, Tall AR and Rothblat GH: Scavenger receptor
class B type I as a mediator of cellular cholesterol efflux to
lipoproteins and phospholipid acceptors. J Biol Chem.
273:5599–5606. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liadaki KN, Liu T, Xu S, Ishida BY,
Duchateaux PN, Krieger JP, Kane J, Krieger M and Zannis VI: Binding
of high density lipoprotein (HDL) and discoidal reconstituted HDL
to the HDL receptor scavenger receptor class B type I. Effect of
lipid association and APOA-I mutations on receptor binding. J Biol
Chem. 275:21262–21471. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Majdalawieh A and Ro HS: PPARgamma1 and
LXRalpha face a new regulator of macrophage cholesterol homeostasis
and inflammatory responsiveness, AEBP1. Nucl Recept Signal.
8:e0042010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC,
Lv YC, Ouyang XP, Yu XH, Kuang HJ, Jiang ZS, et al: PAPP-A
negatively regulates ABCA1, ABCG1 and SR-B1 expression by
inhibiting LXRα through the IGF-I-mediated signaling pathway.
Atherosclerosis. 222:344–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma AZ, Song ZY and Zhang Q: Cholesterol
efflux is LXRalpha isoform-dependent in human macrophages. BMC
Cardiovasc Disord. 14:802014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kämmerer I, Ringseis R, Biemann R, Wen G
and Eder K: 13-hydroxy linoleic acid increases expression of the
cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates
apoA-I-dependent cholesterol efflux in RAW264. 7 macrophages.
Lipids Health Dis. 10:2222011. View Article : Google Scholar : PubMed/NCBI
|
